News | August 08, 2007

Nuclear Oncology Medical Care First in Illinois to Install AccuBoost

August 8, 2007 - Nuclear Oncology Medical Care, DuPage Oncology Center in Winfield, IL, is the first cancer center in the state to install and use the AccuBoost System for image-guided treatment of breast cancer.

The AccuBoost’s first patient in Illinois is 76-year old Mrs. G. Miller who will receive the site-specific radiation treatment for breast cancer in sessions performed over eight days. The treatment is designed to deliver focused radiation to the lumpectomy cavity while minimizing the unintended exposure to the heart and lungs.

"This noninvasive, real-time image-guided treatment ensures better targeting of the lumpectomy cavity and makes it possible to see what you treat and treat what you see," said DuPage Oncology Center Radiation Oncologist, Dr. Dennis Galinsky.

Dr. Anantha Murthy, Associate Professor of Radiation Oncology at Rush Medical College and DuPage Oncology Center said, "When I saw this system at the recent American Brachytherapy Society meeting, I knew we needed to make it available to our patients. Targeting the boost dose has always been a challenge; this system solves the problem."

"Typically delivered prior to the main external beam breast irradiation, AccuBoost is presently used as a replacement for the electron boost that normally would follow the standard treatment," said DuPage Oncology Center's Chief of Medical Physics, Dr. Mohamed Hamadeh. "The breast is immobilized and imaged in a manner similar to mammography allowing a special applicator to be positioned, delivering the radiation with far better accuracy."

For more information: www.AccuBoost.com

Related Content

Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...